Amalgamated Bank cut its holdings in Ventas, Inc. (NYSE:VTR – Get Rating) by 6.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 100,257 shares of the real estate investment trust’s stock after selling 7,036 shares during the period. Amalgamated Bank’s holdings in Ventas were worth $6,192,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently made changes to their positions in the business. Bank of America Corp DE raised its position in shares of Ventas by 7.9% in the 1st quarter. Bank of America Corp DE now owns 1,736,954 shares of the real estate investment trust’s stock worth $107,274,000 after acquiring an additional 126,663 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in Ventas by 45.0% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 66,415 shares of the real estate investment trust’s stock valued at $4,102,000 after buying an additional 20,610 shares in the last quarter. Neuberger Berman Group LLC increased its position in Ventas by 4,732.3% in the 1st quarter. Neuberger Berman Group LLC now owns 794,230 shares of the real estate investment trust’s stock valued at $49,059,000 after buying an additional 777,794 shares in the last quarter. Sawtooth Solutions LLC bought a new stake in Ventas in the 1st quarter valued at about $421,000. Finally, EP Wealth Advisors LLC bought a new stake in Ventas in the 1st quarter valued at about $240,000. 92.67% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
VTR has been the subject of a number of research analyst reports. Raymond James decreased their target price on Ventas from $60.00 to $55.00 and set a “strong-buy” rating for the company in a research report on Wednesday, August 31st. Mizuho decreased their target price on Ventas from $65.00 to $61.00 and set a “buy” rating for the company in a research report on Friday, July 1st. Evercore ISI set a $59.00 target price on Ventas in a research report on Monday, June 20th. Morgan Stanley boosted their price objective on Ventas from $52.00 to $54.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 31st. Finally, Jefferies Financial Group raised Ventas from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $58.00 to $59.00 in a report on Thursday, June 30th. Three investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $61.00.
Ventas Price Performance
Ventas Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 14th. Shareholders of record on Monday, October 3rd will be issued a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 3.75%. Ventas’s dividend payout ratio (DPR) is 3,600.72%.
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries – healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population.
- Get a free copy of the StockNews.com research report on Ventas (VTR)
- Kroger’s is Your One-Stop Consumer Staples Stock
- Adobe Perfects the Art of the Faceplant for Investors
- Tax Credits are the Incentives in the Inflation Reduction Act
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- 3 Banks Worth Considering For Q4
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.